Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2018 · 10-Q
Revenue$0.00$0.00— vs Q1 2017 Net Income-$68.52M-$68.52MN/M vs Q1 2017 EPS Diluted-$0.89-$0.89N/M vs Q1 2017 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
-$62,751,000
N/M
Operating Cash Flow-$67,413,000N/M Free Cash Flowderived-$72,778,000N/M ended Mar 31, 2018 · filed May 2, 2018 · 32 d after period end